Thursday - February 26, 2026

Category Archives: Pharmaceuticals & Biotech

Metastatic Colorectal Cancer Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Daiichi Sankyo Company, Mirati Therapeutics, Apollomics, Treos Bio

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 150+ key companies continuously working towards developing 180+ Metastatic Colorectal Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and … Continue reading →

Biliary Tract Cancer Market: Expanding Revenue Landscape to 2034 – DelveInsight | AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharma, Eisai, Merck

The Key Biliary Tract Cancer Companies in the market include – Merck Sharp & Dohme, AstraZeneca, Taiho Oncology, Delcath Systems, TransThera Sciences (Nanjing), Basilea Pharmaceutica, Eisai, Zymeworks, BeiGene, Xencor, Inc., Bristol-Myers Squibb, Leap Therapeutics, Compass Therapeutics, Boehringer Ingelheim, ZielBio, Inc., … Continue reading →

Primary Biliary Cholangitis Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Intercept Pharma, Enanta Pharma, COUR Pharma, Novartis, Gannex Pharma, Nanjing Chia-tai Tianqing Pharm

The Key Primary Biliary Cholangitis Companies in the market include – CymaBay Therapeutics, Inc., Zydus Therapeutics Inc., Gannex Pharma Co., Ltd., Nanjing Chia-tai Tianqing Pharma, Intercept Pharmaceuticals, Enanta Pharmaceuticals, COUR Pharmaceutical, Novartis, Merck, Mirum Pharmaceuticals, Inc., Genfit, CymaBay Therapeutics, Inc., … Continue reading →

Obsessive Compulsive Disorder Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Biohaven Pharma, AbbVie, Biohaven Pharma, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche

The Key Obsessive Compulsive Disorder Companies in the market include – Biohaven Pharmaceuticals, Inc., AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, and others.   DelveInsight’s “Obsessive Compulsive Disorder Market Insights, Epidemiology, … Continue reading →

Pulmonary Fibrosis Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Pulmonary Fibrosis pipeline constitutes 110+ key companies continuously working towards developing 140+ Pulmonary Fibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!

As investors search for “stocks under $5 to buy now,” “small-cap growth stocks 2026,” “AI healthcare stocks,” “quantum computing stocks,” and “emerging Nasdaq breakout stocks,” several under-the-radar companies are drawing increased attention across financial media platforms and AI-driven discovery engines … Continue reading →

Microcap Stocks: AMLM, NGTF, BMXI, FAGI, RNWF Gaining Momentum – More Inside

As investors increasingly search for “OTC breakout stocks,” “gold stocks under $1,” “critical minerals penny stocks,” “renewable energy microcaps,” and “blockchain infrastructure stocks,” a select group of OTC-listed companies is drawing speculative interest heading into 2026. Below is a forward-looking … Continue reading →

Ophthalmoscopes Market to Reach USD 294.90 Million by 2034, Growing at 5.24% CAGR | Rising Demand for Digital and Direct Ophthalmoscopes Drives Global Expansion, analyses DelveInsight

Ophthalmoscopes Market Leading ophthalmoscopes companies in the market include Baxter, HEINE Optotechnik GmbH & CO. KG, Keeler, US Ophthalmic, Rudolf Riester GmbH, Opticlar, Zumax Medical Co., Ltd., Girodmedical, Adam Rouilly Ltd., Timesco Healthcare Ltd., Zhejiang Honsun Medical Technology Co., Ltd., … Continue reading →

RINVOQ Market Growth Accelerates Across IBD, Dermatology, and Rheumatology as Global Sales Momentum Strengthens | DelveInsight

RINVOQ Market The global immunology market is witnessing a significant transformation as RINVOQ (upadacitinib) continues to demonstrate strong prescription growth, expanding indications, and robust revenue performance. DelveInsight’s “RINVOQ Sales Forecast, and Market Size Analysis – 2034” report provides comprehensive insights … Continue reading →